whitepaper
1 December 2020 | By Hongshan Li. PhD (Sartorius. Fremont CA)
Bioanalytical systems have rapidly developed over the past 10 years for lead selection during cell-line development. The advanced technologies for the timely and cost-effective screening of antibodies or vaccines involve consideration of quantitation, kinetics and other critical quality attributes (CQA).